About Us
SANGUINE is a pioneering project dedicated to advancing early detection of hematological malignancies through the development of a state-of-the-art blood test. Our consortium is composed of leading experts and institutions in hematology, oncology, genomics, and diagnostics. With a multidisciplinary approach, we aim to revolutionize cancer research by integrating cutting-edge technologies and interdisciplinary teams to create innovative solutions that have a real impact on society. SANGUINE recognizes the importance of Social Sciences and Humanities (SSH) in this process, ensuring the inclusion of human interaction and ethical considerations to enhance medical decision-making, address the needs of medical professionals and patients, and achieve effective implementation.
Our Approach
SANGUINE adopts a multidisciplinary framework, merging STEM with SSH principles. We prioritize five social principles—beneficence, non-maleficence, autonomy, justice, and explainability—intertwining sociology, psychology, ethics, and other SSH disciplines for data analysis. By addressing bias, under-representation, and ethical aspects, our blood test becomes inclusive and reliable. Legal, Policy, Economics, and Public Administration branches shape regulatory frameworks and facilitate implementation. Effective communication and stakeholder involvement ensure result dissemination and engagement, fostering collaboration with patients, caregivers, health professionals, and relevant associations throughout the process
Partners
TAU manages and coordinates the project's activities while also characterizing genomic DNA biomarkers.
Work Package 6 Leader: Contributes to dissemination and communication activities, leads stakeholder and patient involvement, and policy outreach.
JaxBio is responsible for biomarker discovery and technology development.
A clinical site responsible for the medical implementation of the project, for collecting and analyzing the required medical samples.
A clinical site responsible for the medical implementation of the project, for collecting and analyzing the required medical samples.
PredictBy will support data collection and conduct impact assessment for the project to establish its societal and health-related impact.
Fzmb supports partners with an exclusive microarray printing service, providing state-of-the-art microdispensing technologies for array design, production and data analysis.
A clinical site responsible for the medical implementation of the project, for collecting and analyzing the required medical samples.
.png){kind=logo}
A clinical site responsible for the medical implementation of the project, for collecting and analyzing the required medical samples.
A clinical site responsible for the medical implementation of the project, for collecting and analyzing the required medical samples. TASMC is also responsible for planning, execution and overseeing the global SANGUINE clinical trial.
Orientos has dual roles: partnering for management, communication, dissemination, and exploitation, and hosting a CRO overseeing the clinical study.
Collaborators
Clinical Research Organisation (CRO), plays a pivotal role in supervising and managing the clinical studies while ensuring adherence to regulatory requirements and overseeing the overall regulatory strategy.
Empowering Early Detection, Transforming Lives
